Propolis
In clinical developmentAlso known as Bee propolis, propolis (bee glue), propolis (bee glue) extract.
Recent clinical, regulatory, research and industry developments relating to this drug.
Propolis as a Treatment Option for Hand Foot and Mouth Disease
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Propolis as a Treatment Option for Hand Foot and Mouth Disease
Recent completions
Trials that read out recently, adding to the completed evidence base.
Propolis as a Treatment Option for Hand Foot and Mouth Disease
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Journals, researchers & institutions
- Oxidative medicine and cellular longevity1
- Gan SH1
- Pasupuleti VR1
- Ramesh N1
- Sammugam L1
- Human Genome Center1
- Institute of Food Security and Sustainable Agriculture1
- Universiti Malaysia Kelantan1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 2 of the same disease areas as Propolis in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials